Letter

Angiotensin receptor blockers and myocardial infarction

BMJ 2005; 330 doi: 10.1136/bmj.330.7502.1269 (Published 26 May 2005)
Cite this as: BMJ 2005;330:1269.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Analysis of evidence is incomplete and inaccurate

  1. John McMurray, professor of medical cardiology (j.mcmurray@bio.gla.ac.uk)1
  1. 1Department of Cardiology, Western Infirmary, Glasgow G11 6NT

    Editor—Verma and Strauss say that, compared with angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers do not reduce (and may increase) the risk of myocardial infarction.1 Their claim represents an incomplete, inaccurate, and misleading “analysis” of the evidence.

    They did not cite the two largest studies that randomised patients to an ACE inhibitor or angiotensin receptor blockers and had the statistical power to evaluate cardiovascular outcomes.2 3 These had twice …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular